Topical tacrolimus therapy for antibiotic-refractory pouchitis

Area of Science:

• Gastroenterology and Surgery
• Inflammatory Bowel Disease Research
• Pharmacological Interventions

Background:

• Pouchitis is a frequent complication following restorative proctocolectomy for ulcerative colitis, potentially leading to pouch failure.
• Standard oral antibiotic therapy for pouchitis can be ineffective, leading to antibiotic-refractory cases requiring alternative treatments.

Purpose of the Study:

• To evaluate the safety and efficacy of topical tacrolimus as a treatment for antibiotic-refractory pouchitis.

Main Methods:

• A prospective pilot study was conducted involving patients with antibiotic-refractory pouchitis.
• Participants received an 8-week course of tacrolimus enema treatment.
• Efficacy was measured using the Pouchitis Disease Activity Index (PDAI), and safety was assessed by monitoring whole blood tacrolimus trough levels.

Main Results:

• Ten patients with refractory pouchitis were enrolled; no severe adverse events were reported.
• Mean PDAI scores significantly decreased from 15.9 to 7.8 after 8 weeks of treatment (p < 0.01).
• Nine patients experienced clinical symptom improvement, and three achieved complete remission of pouchitis.

Conclusions:

• Topical tacrolimus enema therapy appears to be a safe and effective short-term treatment for the clinical symptoms of antibiotic-refractory pouchitis.
• While complete endoscopic healing was not consistently achieved, tacrolimus may offer early rescue therapy for this condition.
• Further research, including larger, randomized trials, is warranted to confirm these findings.